Cancer centers in Australia and New Zealand gain local access to GrayOS through a partnership with alphaXRT

Radiation therapy departments in Australia and New Zealand are facing the same problem as departments in North America and Europe. Demand for care keeps rising, treatments are becoming more complex, and the number of machines, therapists and staff hours does not grow at the same pace. Today, alphaXRT and Gray Oncology Solutions are announcing a distribution partnership that gives RT departments across both countries local access to GrayOS, the Care Orchestration Platform for oncology.
When demand outgrows capacity
Every RT department runs on the same equation: patient demand has to fit into finite capacity. Machines, staff, physician availability and imaging slots are all limited, and the schedule is where those limits meet.
When demand grows faster than capacity, departments end up trading wait times against staff workload and operating costs, often several times a week. An urgent patient arrives on a day that is already full, and a dozen other appointments have to move. A machine goes down and the team spends the morning working out who can be moved, who can skip a fraction and who cannot wait. In many departments, the rules that make these decisions possible live in the heads of one or two experienced schedulers.
The tools most departments rely on were built to record care and run machines safely, and balancing patients against capacity was never part of their job. That work falls to people instead, through spreadsheets, phone calls and manual workarounds layered on top of the OIS. The cost shows up in administrative hours that could go to patients, longer delays before treatment starts, and operating costs that climb every time the schedule has to be rebuilt by hand.
The same tension, in very different health systems
GrayOS is used today by cancer centers in North America and Europe, including in Canada, the United States and France. These are very different health systems. Canadian centers work within provincial public funding, American centers operate in a competitive market where access drives referrals, and French centers such as Gustave Roussy combine public funding with national cancer programs.
Yet the conversations we have with RT teams sound remarkably similar from one country to the next. Schedules look full while capacity is quietly lost, and a single disruption can consume hours of manual rework before anyone sees where the next bottleneck will land. That consistency is what convinced us the problem is structural, and it is why Australia and New Zealand are the next place we're bringing GrayOS.
What GrayOS does for an RT department
GrayOS sits above the oncology information system the department already uses. It reads treatment plans, orders and existing appointments, and writes bookings back, so the OIS remains the system of record and therapists at the machine keep working as they do today.
On top of that data, GrayOS applies the department's own rules to allocate patients to treatment machines, simulation, imaging and physician consults. When something changes, such as an urgent start, a cancellation or a machine breakdown, it rebalances against the same rules and shows the team every knock-on effect before anything is saved. The final decision always stays with the people running the department.
Across the centers using GrayOS, administrative time has dropped by 80%, wait times by 17%, and departments treat 13% more patients without additional resources.
Why alphaXRT chose GrayOS
Few teams know radiation therapy departments in Australia and New Zealand as well as alphaXRT. For more than 30 years, its team has worked alongside RT departments in both countries, from treatment delivery and planning to medical physics and QA. That daily proximity is what led alphaXRT to distribute GrayOS. Its team sees firsthand how heavily the imbalance between demand and capacity weighs on these departments, and wanted to bring them a way to manage it.
For departments, it also means a team close to home to talk to from the very first conversation.
"Our partnership with Gray Oncology Solutions represents an exciting opportunity for radiation oncology departments across Australia and New Zealand. By introducing intelligent solutions like GrayOS, we're helping our customers address real operational challenges, maximise existing resources and ultimately improve the experience for both clinical teams and their patients."
Nick Evans, Chief Commercial Officer, alphaXRT
"Expanding into Australia and New Zealand is an exciting milestone for Gray. Partnering with alphaXRT gives us the opportunity to combine our technology with their established regional expertise and strong customer relationships. Together, we look forward to helping oncology departments improve operational efficiency, unlock treatment capacity and deliver more timely care to patients across the region."
André Diamant, CEO and Co-Founder, Gray Oncology Solutions
What this means for departments in Australia and New Zealand
RT departments interested in GrayOS can now start the conversation with alphaXRT directly. The alphaXRT team will be their local point of contact, from the first demonstration through deployment and ongoing support, with Gray's team working alongside them.
If your department is feeling the gap between demand and capacity, contact the alphaXRT team at info@alphaxrt.com or through their contact page to see how GrayOS could work with your systems and your rules.
About alphaXRT
Founded in 1990, alphaXRT is the leading independent supplier of radiation oncology solutions across Australia and New Zealand. With offices in Sydney and Auckland, and team members throughout Melbourne, Brisbane, and Perth, the company provides local expertise and support to radiation therapy departments across the region.
Supporting treatment planning, patient positioning, treatment delivery, medical physics, and QA, alphaXRT provides innovative radiation oncology solutions through partnerships with leading vendors including Accuray, MVision, Sun Nuclear, and MacroMedics and many others. In 2026, alphaXRT became part of the EBOS MedTech group, further strengthening its ability to serve customers across Australia and New Zealand. Learn more at alphaxrt.com.
